艾美捷科技代理Abliance品牌全系列产品

Abliance是一家法国的抗体制造商和服务提供商，由专家组成的团队，在细胞培养、蛋白质工程和质量控制方面拥有深厚专业知识，专注为体外诊断（IVD）及科研领域提供高合规性抗体解决方案，满足研究和诊断工业市场的抗体需求。

▍Abliance公司产品提供丰富可选择的抗体库

● Abliance的二抗产品为多克隆抗体，通过使用人或动物免疫球蛋白对实验动物（兔、山羊或绵羊）进行高效免疫后获得。收集的免疫血清除含有目标特异性抗体外，还包含非特异性抗体及血清杂蛋白。

● Globulins：经过系列非特异性纯化步骤（脱脂处理→硫酸铵沉淀→透析）后获得球蛋白组分，此中间产物适用于免疫沉淀技术。

● Affinity purified antibodies：随后通过亲和层析对抗体进行纯化，从而确保高特异性。此外，抗鼠/兔IgG（H+L）二抗需在装有人源IgA/IgG/IgM的凝胶层析柱上进行系统化吸附处理，确保其与人源IgA/IgG/IgM无交叉反应。

● Fragments：Abliance提供经酶切获得的F(ab')₂和Fab片段，适用于免疫组化/细胞学检测及流式细胞术等场景。相较于含Fc区的完整抗体，这些片段能显著降低非特异性结合。其更小的分子量可增强细胞和组织渗透性。

● Labeled antibodies：Abliance供应多样标记物复合体：球蛋白组分、纯化抗体及Fab/F(ab')₂片段，可与荧光染料（异硫氰酸荧光素）、酶类（过氧化物酶、碱性磷酸酶、β-半乳糖苷酶、葡萄糖氧化酶）及生物素进行偶联。

▍Abliance部分产品列表

Toronto Research Chemical建立于1982年，致力于为生物医药研发人员提供小分子有机物，库存超过57000种，并通过一系列方法保证标准物质的纯度。

Toronto Research Chemicals, TRC, was founded in 1982 by Dr. David Dime to manufacture and supply researchers in the biomedical fields with specialized complex organic small molecules that were not commercially available. In 1983, the company was incorporated in Ontario as Toronto Research Chemicals Inc. It was initially located at the University of Toronto. As the business expanded, larger facilities were required to accommodate the growth.

Today, Toronto Research Chemicals Inc. employs about 150 full time staff, of which approximately 80 are PHD's, operating in a 65,000 square foot facility. TRC, currently manufactures and distributes in excess of 33,000 products to more than 65 countries.

Toronto Research Chemical的产品涵盖：

Activators; Affinity Chromatography; Agonists; Agro-Products; Aldehyde Labeling Reagents; Aldehydes; Amines; Amino Acids & Derivatives; Anti-virals; Antibiotics; Apoptosis; Benzodiazepines; Biotin Derivatives; Boron Derivatives; Carbohydrates; Catalysts; Charged Bifunctional Reagents; Charged Monofunctional Reagents; Chelating Agents & Ligands; Chiral Reagents; Chromatography Media; Cross Linking Reagents; Crosslinker; CyanineDyes; Detergents; Diagnostics; Dihydropyridine; Dopamines; DrugAnalogues; ElectrophoresisMaterials; Environmental; Enzyme Substrates; Ephedrines; Fatty Acids & Derivatives; Fentanyls; Fluorescent Labels &Indicators; Glucuronides; Glutathione S-Transferase Agents; Glycerols; Glycosidase Inhibitors; Heterocycles; Hydantoins; Impurities; Indole Derivatives; Inhibitors; Inositols; Isotope Labelled Compounds; Labeling and Diagnostics Reagents; Lipids; Lysergic Acid and Derivatives; Maleimide Derivatives; Mercaptans/Thiols; Metabolites; Methadones and Analogues; Miscellaneous Compounds; Morphine Based Alkaloids; MTS & Sulfhydryl Active Compounds; Mutagenesis Research Chemicals; Neurochemicals; Neutral Bifunctional Reagents; Neutral Monofunctional Reagents; Nicotine Derivatives; Nitric Oxide Reagents; Non-nucleoside Reverse Transcriptase; Nucleotides; Oligosaccharides; Opium Alkaloids - Natural and Derivatives; Peptides; Pharmaceuticals; Phenethylamines; Phosphorylating and Phosphitylating Agents; Phosphorylcholine Derivatives; Photoaffinity Labels; Polyethyleneglycol Derivatives; Polymers; Protein Kinase Inhibitors and Activators; Pyridyl Disulfides; Retinoids; Selenium Compounds; Sphingosine Derivatives; Spin Labeling Compounds; Steroids; Sulfonyl Chlorides; Tyrosine Kinase Inhibitors; Wittig Reagents.

更多详情请联系 

艾美捷科技有限公司

全国服务热线：400-6800-868

邮箱：sales@amyjet.com

网站：www.amyjet.com

艾美捷科技代理Quartett品牌

Quartett公司于1986年在德国柏林创立，始终致力于癌症防治领域并推动肿瘤诊断技术革新。quartett专注于两大核心业务：为解剖病理学/免疫组化（IHC）领域生产单克隆抗体，同时为制药工业及科研机构提供合成多肽产品。

▍Quartett两大核心技术

● 兔源重组单克隆抗体技术平台：突破传统鼠源抗体的局限。相较于鼠类免疫系统，兔源免疫系统具有显著优势——可识别更微小表位（≤5个氨基酸）、产生亲和力达10⁻¹²M的高特异性抗体，这使得quartett公司开发的诊断试剂在癌症检测中展现出卓越性能（如PD-L1检测灵敏度92.7%）。

● 合成肽制备技术：专业生产HPLC纯度＞95%的定制肽，包括蛋白酶抑制剂及抗体生产用免疫原肽。该平台的成功更直接推动了兔源重组抗体技术的突破性发展，形成从合成肽到高价值诊断抗体的完整技术闭环。所有试剂均优化适配全自动染色平台（如Roche Ventana/Leica BOND）及人工染色流程。

▍Quartett部分产品列表